Clinical Trials Logo

Filter by:
NCT ID: NCT02349594 Completed - Crohn Disease Clinical Trials

Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease

Start date: January 2014
Phase: Phase 4
Study type: Interventional

To evaluate the effects of infusion of a Fish oil-based lipid emulsion on TNF-α production and other relevant immune functions. A soybean oil emulsion, rich in the omega-6 polyunsaturated fatty acid linoleic acid, will serve as control.

NCT ID: NCT02349399 Completed - Acne Vulgaris Clinical Trials

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

Start date: May 1, 2015
Phase: N/A
Study type: Observational

The study objectives are to characterize new users of Cyproterone Acetate / Ethinylestradiol (CPA/EE) in 2011/2012 and in 2014 according to demographics, treatment characteristics, previous diagnosis of acne, hirsutism or other hyperandrogenic conditions, previous acne treatment and (concomitant) use of hormonal contraceptives identified in Healthcare Databases in the UK (THIN), the Netherlands (PHARMO) and Italy (HSD).

NCT ID: NCT02349282 Completed - Clinical trials for Deficiency, Vitamin D

The Effect of Calcifediol (Hy.D 25 SD/S) and Vitamin D3 on Muscle Strength in a Frail Elderly Population

D-Fit
Start date: December 2014
Phase: N/A
Study type: Interventional

In an ageing population, the need for interventions to help older people remain healthy, active and independent for as long as possible, increases. Although several studies suggest a beneficial effect of vitamin D3 on maintaining or improving muscle strength and physical functioning, particularly in vulnerable populations, results are contradicting. Randomized, placebo-controlled trials are needed to further establish the effect of vitamin D on muscle strength in the frail elderly population.The primary aim of this study is to determine the effect of daily supplementation with two different forms of vitamin D on muscle strength in frail elderly people over a period of 24 weeks.

NCT ID: NCT02349165 Completed - Keratoconus Clinical Trials

Standard Versus Transepithelial Corneal Crosslinking

Start date: May 2011
Phase: N/A
Study type: Interventional

The gold standard corneal crosslinking (CXL) technique involves the initial step of epithelial removal, in order to achieve a sufficient treatment effect (meaning: stabilisation of progressive keratoconus (KC). Our aim is to evaluate the effects of transepithelial CXL (TE-CXL), whereby the epithelium is left intact and the cornea is instead treated by a solution composed of 0.1% riboflavin, combined with enhancers, after which standard CXL is performed. This solution seems to facilitate riboflavin penetration into the corneal stroma through the intact epithelium. The investigators expect to achieve a similar effect of TE-CXL with the advantage of a faster healing time and less risk of infections.

NCT ID: NCT02349100 Completed - Aortic Aneurysm Clinical Trials

PET-CT After Nellix Implantation

Start date: January 2015
Phase: N/A
Study type: Observational

To determine FDG uptake following uncomplicated EVAR using the Nellix endoprosthesis. Does uncomplicated EVAR using the nellix endoprosthesis result in increased FDG uptake and false positive PET imaging?

NCT ID: NCT02348723 Completed - Atrial Fibrillation Clinical Trials

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Start date: April 28, 2015
Phase: Phase 4
Study type: Interventional

The primary objective of this trial is to assess the safety of an uninterrupted dabigatran etexilate periprocedural anticoagulant regimen compared to an uninterrupted warfarin regimen in Non-Valvular Atrial Fibrillation (NVAF) patients undergoing Atrial Fibrillation (AF) ablation in a PROBE (Prospective, randomized, open label, blinded end point) active controlled study. Secondary objectives are to assess additional safety endpoints and efficacy in this clinical setting. It is not intended to assess confirmatory hypothesis, this is an exploratory study.

NCT ID: NCT02348632 Completed - Clinical trials for Obstructive Sleep Apnea

"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"

Start date: May 2015
Phase: Phase 3
Study type: Interventional

This is a Phase 3 study to assess the long-term safety and maintenance of efficacy of JZP-110 in subjects who have completed Study 14-002, 14-003, 14-004, 15-004, 15-005, ADX-N05 201, or ADX-N05 202.

NCT ID: NCT02348606 Completed - Clinical trials for Obstructive Sleep Apnea

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

OSA
Start date: May 2015
Phase: Phase 3
Study type: Interventional

This trial is a 12 week, randomized, double-blind, placebo controlled, multicenter, 5-arm parallel group study of safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with OSA.

NCT ID: NCT02348593 Completed - Narcolepsy Clinical Trials

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"

Start date: May 2015
Phase: Phase 3
Study type: Interventional

This trial is a 12-week, randomized, double-blind, placebo controlled, multicenter, 4-treatment parallel group study of the safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with narcolepsy.

NCT ID: NCT02348541 Completed - Clinical trials for Hysteroscopic Adhesiolysis

Usability of the CollaGUARD Adhesion Barrier Following Hysteroscopic Adhesiolysis

Start date: December 2014
Phase: N/A
Study type: Interventional

Assess the feasibility of CollaGUARD following Hysteroscopic Adhesiolysis.